These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31396240)

  • 1. Corrigendum: PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
    Ramirez GA; Rovere-Querini P; Blasi M; Sartorelli S; Di Chio MC; Baldini M; De Lorenzo R; Bozzolo EP; Leone R; Mantovani A; Manfredi AA; Tombetti E
    Front Immunol; 2019; 10():1755. PubMed ID: 31396240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
    Ramirez GA; Rovere-Querini P; Blasi M; Sartorelli S; Di Chio MC; Baldini M; De Lorenzo R; Bozzolo EP; Leone R; Mantovani A; Manfredi AA; Tombetti E
    Front Immunol; 2019; 10():1135. PubMed ID: 31191526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.
    Tombetti E; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bottazzi B; Bozzolo EP; Greco M; Rovere-Querini P; Baldissera E; Del Maschio A; Mantovani A; De Cobelli F; Sabbadini MG; Manfredi AA
    Arthritis Res Ther; 2014 Nov; 16(6):479. PubMed ID: 25394473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmunity in 2016.
    Selmi C
    Clin Rev Allergy Immunol; 2017 Aug; 53(1):126-139. PubMed ID: 28555437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large vessel vasculitis (giant cell arteritis, Takayasu arteritis).
    Wilke WS
    Baillieres Clin Rheumatol; 1997 May; 11(2):285-313. PubMed ID: 9220079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cutaneous alterations in vasculitides : Part 2: Special aspects of diseases of large, medium and small vessels].
    Sunderkötter C; Michl C
    Internist (Berl); 2019 Aug; 60(8):805-813. PubMed ID: 31300830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.
    Simon A; Subra JF; Guilpain P; Jeannin P; Pignon P; Blanchard S; Garo E; Jaillon S; Chevailler A; Renier G; Puéchal X; Bottazzi B; Mantovani A; Delneste Y; Augusto JF
    PLoS One; 2016; 11(1):e0147091. PubMed ID: 26797217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation.
    Fazzini F; Peri G; Doni A; Dell'Antonio G; Dal Cin E; Bozzolo E; D'Auria F; Praderio L; Ciboddo G; Sabbadini MG; Manfredi AA; Mantovani A; Querini PR
    Arthritis Rheum; 2001 Dec; 44(12):2841-50. PubMed ID: 11762945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentraxin-3 as a marker of disease activity in Takayasu arteritis.
    Dagna L; Salvo F; Tiraboschi M; Bozzolo EP; Franchini S; Doglioni C; Manfredi AA; Baldissera E; Sabbadini MG
    Ann Intern Med; 2011 Oct; 155(7):425-33. PubMed ID: 21969341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited.
    Keser G; Aksu K; Direskeneli H
    Rheumatology (Oxford); 2018 May; 57(5):784-790. PubMed ID: 28968895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathology of large-vessel vasculitides.
    Miller DV; Maleszewski JJ
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S92-8. PubMed ID: 21586202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
    Cieślik P; Hrycek A
    Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The modern therapy of systemic vasculitides: perspectives and challenges.
    Novikov PI; Zykova AS; Moiseev SV
    Ter Arkh; 2018 Feb; 90(1):76-85. PubMed ID: 30701763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Large vessel vasculitis : Giant cell arteritis and Takayasu arteritis].
    Villiger PM
    Z Rheumatol; 2017 Aug; 76(6):509-523. PubMed ID: 28638968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus.
    Sahin S; Adrovic A; Barut K; Durmus S; Gelisgen R; Uzun H; Kasapcopur O
    Lupus; 2017 Sep; 26(10):1089-1094. PubMed ID: 28420068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progranulin antibodies in autoimmune diseases.
    Thurner L; Preuss KD; Fadle N; Regitz E; Klemm P; Zaks M; Kemele M; Hasenfus A; Csernok E; Gross WL; Pasquali JL; Martin T; Bohle RM; Pfreundschuh M
    J Autoimmun; 2013 May; 42():29-38. PubMed ID: 23149338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological complications of connective tissue and other "collagen-vascular" diseases.
    Cohen SB; Hurd ER
    Semin Arthritis Rheum; 1981 Aug; 11(1):190-212. PubMed ID: 6116280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombo-embolic and vascular complications in vasculitis syndromes.
    Somer T
    Eur Heart J; 1993 Dec; 14 Suppl K():24-9. PubMed ID: 7907547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis.
    Schmidt WA; Blockmans D
    Curr Opin Rheumatol; 2005 Jan; 17(1):9-15. PubMed ID: 15604899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis and future developments in vasculitis.
    Basu N; Karabayas M; Pusey C
    Best Pract Res Clin Rheumatol; 2018 Feb; 32(1):148-165. PubMed ID: 30526894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.